MucoLife Therapeutics
PrivateLast Round
Accelerator
Sep 6, 2024
Total Funding Raised
$30,000
Company Overview
MucoLife Therapeutics is a biotechnology company developing inhaled therapies for pulmonary mucus obstruction in chronic lung diseases such as COPD and cystic fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MucoLife Therapeutics Comps
Public and private peers based on sector, stage, and business model.
MucoLife Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 6, 2024 |
Key People
Founding team and executive leadership
MucoLife Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 6, 2024
$30K round led by Health Wildcatters
MucoLife Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MucoLife Therapeutics's valuation, stock price, and market status.
